Rob Califf returns to lead the FDA as the U.S. continues to cope with the pandemic and opioid epidemic. The agency also is facing questions about its processes for accelerated drug approvals. Read full article here
Rob Califf returns to lead the FDA as the U.S. continues to cope with the pandemic and opioid epidemic. The agency also is facing questions about its processes for accelerated drug approvals.
Read full article here
Leave a Comment
Your email address will not be published. Required fields are marked with *